Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
Treadmill stress echocardiography (TSE) reveals hidden physiologic limitations in patients with asymptomatic hypertrophic cardiomyopathy (HCM), aiding in diagnosis and prognosis. Many patients with ...
A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.
Your heart is a muscle. As Dr. Noah Moss, an advanced heart failure and transplant cardiologist at the Mount Sinai Fuster Hospital in New York City, puts it, “a very special muscle, but a muscle.” ...
Hypertrophic cardiomyopathy (HCM) is a condition where some of the heart muscle becomes too thick, (a.k.a., hypertrophied, a typical diagnostic criterion is a 15 millimeters or greater left ventricle ...
Everyday Health on MSN
Genetics and family risk: What to know if you have hypertrophic cardiomyopathy (HCM)
Learn how hypertrophic cardiomyopathy (HCM) affects families, the importance of genetic testing, and why regular screening is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results